Shin Maeda

Active 1989–2025

99
Papers
19,157
Citations
60
h-index
92
i10-index

Citations

Citations per year for Shin Maeda1990: 3 citations1991: 1 citations1992: 4 citations1993: 6 citations1994: 7 citations1995: 9 citations1996: 6 citations1997: 9 citations1998: 8 citations1999: 14 citations2000: 24 citations2001: 58 citations2002: 61 citations2003: 68 citations2004: 85 citations2005: 214 citations2006: 359 citations2007: 319 citations2008: 391 citations2009: 421 citations2010: 411 citations2011: 333 citations2012: 354 citations2013: 336 citations2014: 295 citations2015: 253 citations2016: 230 citations2017: 195 citations2018: 178 citations2019: 507 citations2020: 580 citations2021: 577 citations2022: 411 citations2023: 271 citations2024: 377 citations2025: 165 citations2026: 4 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,716 citing papers, 28% of this breakdownChina: 1,270 citing papers, 13.1% of this breakdownJapan: 648 citing papers, 6.7% of this breakdownGermany: 568 citing papers, 5.9% of this breakdownUnited Kingdom: 472 citing papers, 4.9% of this breakdownItaly: 381 citing papers, 3.9% of this breakdownFrance: 302 citing papers, 3.1% of this breakdownAustralia: 248 citing papers, 2.6% of this breakdownSouth Korea: 247 citing papers, 2.5% of this breakdownCanada: 228 citing papers, 2.4% of this breakdownSpain: 207 citing papers, 2.1% of this breakdownIndia: 162 citing papers, 1.7% of this breakdown
0%28%Other 23.1%

Fields

  • Medicine45.8%
  • Biochemistry, Genetics and Molecular Biology36.9%
  • Immunology and Microbiology9.7%
  • Pharmacology, Toxicology and Pharmaceutics2.2%
  • Neuroscience1.6%
  • Agricultural and Biological Sciences0.8%
  • Other3%

Topics

  • Liver Disease Diagnosis and Treatment3.2%
  • NF-κB Signaling Pathways3.1%
  • Helicobacter pylori-related gastroenterology studies3%
  • Immune Response and Inflammation2.8%
  • Adipokines, Inflammation, and Metabolic Diseases2.4%
  • Immune cells in cancer2%
  • Other83.5%

Coauthors

All papers

Open in search
  1. Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production

    Authors: , , , , , , - Science 2007 cited by 1,972

  2. IKK-β links inflammation to obesity-induced insulin resistance

    Authors: , , , , , , , , , - Nature Medicine 2005 cited by 1,755

  3. Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases

    Authors: , , , , , - Cell 2005 cited by 1,792

  4. IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis

    Authors: , , , , - Cell 2005 cited by 1,171

  5. Hepatocyte Necrosis Induced by Oxidative Stress and IL-1α Release Mediate Carcinogen-Induced Compensatory Proliferation and Liver Tumorigenesis

    Authors: , , , , , , - Cancer Cell 2008 cited by 483

  6. EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells

    Authors: , , , , , , , , , - Scientific Reports 2022 cited by 59

  7. Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: A Propensity Score Analysis

    Authors: , , , , , , , , - Hepatology 2019 cited by 167

  8. The E3 Ubiquitin Ligase Itch Couples JNK Activation to TNFα-induced Cell Death by Inducing c-FLIPL Turnover

    Authors: , , , , , , , - Cell 2006 cited by 699

  9. Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cancer Science 2019 cited by 82

  10. Randomized trial of vonoprazan‐based versus proton‐pump inhibitor‐based third‐line triple therapy with sitafloxacin for Helicobacter pylori

    Authors: , , , , , , - Journal of Gastroenterology and Hepatology 2018 cited by 81

  11. Constitutive NF-κB Activation in Colorectal Carcinoma Plays a Key Role in Angiogenesis, Promoting Tumor Growth

    Authors: , , , , , , , , - Clinical Cancer Research 2009 cited by 239

  12. Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab

    Authors: , , , , , , , , , , , , , , , , - The Oncologist 2023 cited by 41

  13. Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial

    Authors: , , , , , , , , , , , , , , , , - BMC Cancer 2019 cited by 77

  14. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4

    Authors: , , , , , , , , - Nature 2004 cited by 358

  15. Activation of STING in pancreatic cancer-associated fibroblasts exerts an antitumor effect by enhancing tumor immunity

    Authors: , , , , , , , , , , , , , , - Scientific Reports 2024 cited by 17

  16. Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression

    Authors: , , , , - Cancer Cell 2004 cited by 606

  17. Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2011 cited by 258

  18. The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers

    Authors: , , , , , , , , , , , , - PLoS ONE 2009 cited by 143

  19. Deletion of Apoptosis Signal-Regulating Kinase 1 Attenuates Acetaminophen-Induced Liver Injury by Inhibiting c-Jun N-Terminal Kinase Activation

    Authors: , , , , , , , , , , , - Gastroenterology 2008 cited by 250

  20. Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis

    Authors: , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 143

  21. Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinase

    Authors: , , , , , , , , , , , , , - Hepatology 2011 cited by 88

  22. Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing

    Authors: , , , , , , , - Science 2005 cited by 751

  23. Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer

    Authors: , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 108

  24. A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion

    Authors: , , , , , , , , , , , , , , , , , - Scientific Reports 2016 cited by 79